Login / Signup

Surface antibody changes protein corona both in human and mouse serum but not final opsonization and elimination of targeted polymeric nanoparticles.

Sara CapollaFederico ColomboLuca De MasoPrisca MauroPaolo BertoncinThilo KähneAlexander EnglerLuis NúñezRuben SpretzGustavo LarsenMichele Dal BoGiuseppe ToffoliPaolo Macor
Published in: Journal of nanobiotechnology (2023)
The results clearly indicate the presence of complement proteins on PNPs surface but partially derived from an unspecific deposition rather than an effective complement activation. The presence of a targeting antibody favors the activation of the classical pathway, but its absence allows an increased activation of the alternative pathway. This results in similar opsonization of both PNPs and similar phagocytosis by macrophages, without an impairment of the activity of circulating complement system and, consequently, not enhancing the susceptibility to infection.
Keyphrases
  • cancer therapy
  • drug delivery
  • amino acid
  • protein protein
  • drug release
  • pluripotent stem cells